Clinical trial links oncolytic immunoactivation to survival in glioblastoma.

Autor: Ling AL; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Solomon IH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Landivar AM; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Nakashima H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Woods JK; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Santos A; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Masud N; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Fell G; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA., Mo X; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Yilmaz AS; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Grant J; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Zhang A; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Bernstock JD; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Torio E; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Ito H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Liu J; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Shono N; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Nowicki MO; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Triggs D; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Halloran P; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Piranlioglu R; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Soni H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Stopa B; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Bi WL; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Peruzzi P; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Chen E; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Malinowski SW; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Prabhu MC; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Zeng Y; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Carlisle A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wen PY; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee EQ; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nayak L; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chukwueke U; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gonzalez Castro LN; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Dumont SD; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Batchelor T; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Kittelberger K; ClearPoint Neuro, Solana Beach, CA, USA., Tikhonova E; BostonGene, Waltham, MA, USA., Miheecheva N; BostonGene, Waltham, MA, USA., Tabakov D; BostonGene, Waltham, MA, USA., Shin N; BostonGene, Waltham, MA, USA., Gorbacheva A; BostonGene, Waltham, MA, USA., Shumskiy A; BostonGene, Waltham, MA, USA., Frenkel F; BostonGene, Waltham, MA, USA., Aguilar-Cordova E; Candel Therapeutics, Needham, MA, USA., Aguilar LK; Candel Therapeutics, Needham, MA, USA., Krisky D; Candel Therapeutics, Needham, MA, USA., Wechuck J; Candel Therapeutics, Needham, MA, USA., Manzanera A; Candel Therapeutics, Needham, MA, USA., Matheny C; Candel Therapeutics, Needham, MA, USA., Tak PP; Candel Therapeutics, Needham, MA, USA., Barone F; Candel Therapeutics, Needham, MA, USA., Kovarsky D; Department of Molecular Cell Biology, Weizmann Institute of Medical Sciences, Tel Aviv, Israel., Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Medical Sciences, Tel Aviv, Israel., Suvà ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA., Ligon K; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Reardon DA; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chiocca EA; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. eachiocca@bwh.harvard.edu.

Publikováno v: Nature [Nature] 2023 Nov; Vol. 623 (7985), pp. 157-166. Date of Electronic Publication: 2023 Oct 18.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Abstracts of the 7^th World Congress of Psycho-Oncology.

Publikováno v: Psycho-Oncology. Sep2004 Supplement 2, Vol. 13, p1-233. 233p.